Come visit SonoMotion at the American Urological Association conference in New Orleans on May 13-15 (Booth #1909).
SonoMotion completes initial close of $11.5 Million Series-C funding round co-led by UWH LLC and Advance MedTech Holdings Pte. Ltd.
Journal of Urology publishes University of Washington First-In-Human clinical trial results from the first 19 subjects treated by BWL. Article selected for the cover of the May edition (press release)
SonoMotion treats its 40th subject in the Break Wave Feasibility First-In-Human clinical trial.
SonoMotion secures a $400,000 Commercial Readiness Program (CRP) SBIR grant from the NIH.
SonoMotion closes $10M Series-B round co-led by Advance MedTech Holdings Pte. Ltd., MedVenture Partners Inc and BioVentures. Link to press release.
SonoMotion initiates First-In-Human clinical trial of its Break WaveTM stone fragmentation system
SonoMotion secures a $3M SBIR Phase IIB grant from the NIH in support of its Break WaveTM First-In-Human clinical trial. Planned sites include UW, UBC, UCSD, Cleveland Clinic and Chesapeake Urology.
GE Healthcare and SonoMotion sign a second co-development agreement and expand their strategic relationship with an updated OEM agreement.
SonoMotion receives Health Canada ITA approval to initiate its Break WaveTM First-In-Human clinical trial in Canada.
SonoMotion receives FDA IDE approval to initiate its Break WaveTM First-In-Human clinical trial in the United States.
GE Healthcare and SonoMotion establish a strategic partnership and sign a definitive OEM agreement and co-development agreement.
SonoMotion receives a $1.0M SBIR Commercial Readiness Program grant from the NIH for the development of Stone ClearTM.
SonoMotion closes on a $4.6M Series-A round led by MedVenture Partners Inc. and with a significant participation by Bioventures Investors.
SonoMotion secures a $1.75M SBIR FastTrack grant from the NIH for the development of Break WaveTM.
SonoMotion receives a $350,000 grant from NASA and NSBRI to accelerate development of Break WaveTM.
SonoMotion wins Runner-Up and $50,000 in the prestigious primeUC life science startup competition organized by the University of California and Johnson & Johnson.
Dr. Doug Corl joins SonoMotion as its Chief Technology Officer bringing over 35 years of experience in developing commercial ultrasound-based medical devices.
SonoMotion secures a $1.75M non-dilutive SBIR grant funding from the NIH for the development of Stone ClearTM